Management of incidental STIC lesions with and without BRCA mutations: a survey of current clinical practice in Austria, Germany, and Switzerland - Scorecard - MDSpire

Management of incidental STIC lesions with and without BRCA mutations: a survey of current clinical practice in Austria, Germany, and Switzerland

  • By

  • Natalia Anna Kaufmann

  • Peter Oppelt

  • Christoph Grimm

  • Julia Lastinger

  • Teresa Eichinger

  • Philip Trautner

  • Anja Hartl

  • Stefan Raidl

  • Dariga Ramazanova

  • Caroline Ines Preuss

  • April 20, 2026

  • 0 min

Share

Clinical Scorecard: Clinical Approaches to Incidental STIC Lesions in Patients with and without BRCA Mutations: Insights from a Survey in Austria, Germany, and Switzerland

At a Glance

CategoryDetail
ConditionSerous Tubal Intraepithelial Carcinoma (STIC)
Key MechanismsCharacterized by significant atypia and aberrant p53 staining; associated with high-grade serous ovarian cancer.
Target PopulationPatients with isolated STIC, particularly those with BRCA mutations.
Care SettingGynecological departments in German-speaking countries.

Key Highlights

  • STIC lesions can indicate a risk of developing high-grade serous carcinomas.
  • Prevalence of isolated STIC is significantly higher in BRCA-positive patients.
  • Current guidelines show discrepancies in management practices across regions.
  • The SEE-FIM protocol is essential for the proper examination of fallopian tube specimens.
  • Increased awareness of hereditary breast and ovarian cancer is leading to more frequent STIC diagnoses.

Guideline-Based Recommendations

Diagnosis

  • Utilize the SEE-FIM protocol for surgical specimens.
  • Consider staging procedures to exclude high-grade lesions.

Management

  • Peritoneal staging is recommended without lymph node dissection.

Monitoring & Follow-up

  • Follow-up care should be standardized to ensure consistent management.

Risks

  • STIC is associated with a cumulative risk of peritoneal carcinomatosis.

Patient & Prescribing Data

Women with isolated STIC, particularly those with BRCA mutations.

Risk-reducing salpingo-oophorectomies are increasing due to genetic counseling.

Clinical Best Practices

  • Standardize clinical algorithms for managing STIC.
  • Ensure consistent application of evidence-informed care across regions.

References

Original Source(s)

Related Content